Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR Surgical Company (NASDAQ: STAA, “STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction. Under the terms of the amended agreement, Alcon will purchase all outstanding shares of STAAR for $30.75 per share in cash. This purchase price increase represents an additional approximately $150 million in equity value for stockholders.
Read the full article: Alcon Announces Amended Merger Agreement with STAAR Surgical //
Source: https://www.businesswire.com/news/home/20251209560189/en/Alcon-Announces-Amended-Merger-Agreement-with-STAAR-Surgical